nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—Clonidine—SLC22A3—prostate cancer	0.109	0.34	CrCbGaD
Lofexidine—Clonidine—SLC22A1—prostate cancer	0.0778	0.244	CrCbGaD
Lofexidine—Clonidine—CYP3A5—prostate cancer	0.0628	0.197	CrCbGaD
Lofexidine—Clonidine—CYP1A1—prostate cancer	0.0426	0.134	CrCbGaD
Lofexidine—Clonidine—CYP3A4—prostate cancer	0.0272	0.0852	CrCbGaD
Lofexidine—ADRA2A—Signaling Pathways—LRP2—prostate cancer	0.000455	0.000668	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HPGDS—prostate cancer	0.000453	0.000666	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CD—prostate cancer	0.000451	0.000662	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP2C19—prostate cancer	0.000451	0.000662	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKR1C3—prostate cancer	0.00045	0.000661	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRB2—prostate cancer	0.000449	0.000659	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKACB—prostate cancer	0.000448	0.000657	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SERPINE1—prostate cancer	0.000446	0.000655	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CX3CL1—prostate cancer	0.000446	0.000655	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—P4HB—prostate cancer	0.000446	0.000655	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTT1—prostate cancer	0.00044	0.000646	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ACHE—prostate cancer	0.00044	0.000646	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—VAV3—prostate cancer	0.000438	0.000643	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HIST1H2BG—prostate cancer	0.000438	0.000643	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—THBS1—prostate cancer	0.000436	0.000641	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PPP3CA—prostate cancer	0.000436	0.000641	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP2A6—prostate cancer	0.000435	0.000638	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GRB7—prostate cancer	0.000434	0.000637	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDE4D—prostate cancer	0.000434	0.000637	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ANXA1—prostate cancer	0.00043	0.000631	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS3—prostate cancer	0.000426	0.000625	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ITPR1—prostate cancer	0.000425	0.000623	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKR1C3—prostate cancer	0.000423	0.000621	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HIST1H4H—prostate cancer	0.000423	0.000621	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CXCL8—prostate cancer	0.000422	0.00062	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCZ—prostate cancer	0.000422	0.00062	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PRKACB—prostate cancer	0.000421	0.000618	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP17A1—prostate cancer	0.000416	0.000611	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—JAK2—prostate cancer	0.000414	0.000608	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GNG5—prostate cancer	0.000413	0.000606	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CG—prostate cancer	0.000413	0.000606	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGFR4—prostate cancer	0.000408	0.000599	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PARP1—prostate cancer	0.000408	0.000599	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CALCA—prostate cancer	0.000403	0.000591	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NCOA2—prostate cancer	0.000397	0.000583	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL12—prostate cancer	0.000393	0.000577	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CB—prostate cancer	0.000393	0.000577	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—prostate cancer	0.00038	0.000558	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SLC5A5—prostate cancer	0.000378	0.000556	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CG—prostate cancer	0.000375	0.00055	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP9—prostate cancer	0.00037	0.000544	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP2E1—prostate cancer	0.00037	0.000543	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NQO1—prostate cancer	0.000365	0.000537	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CD—prostate cancer	0.000363	0.000533	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IL2—prostate cancer	0.000361	0.00053	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TH—prostate cancer	0.00036	0.000529	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFBR1—prostate cancer	0.000359	0.000528	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTHLH—prostate cancer	0.000359	0.000528	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCQ—prostate cancer	0.000359	0.000527	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NGFR—prostate cancer	0.000359	0.000527	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP3A4—prostate cancer	0.000356	0.000523	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAP3K7—prostate cancer	0.000355	0.000521	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKR1C3—prostate cancer	0.000354	0.000519	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKACB—prostate cancer	0.000352	0.000517	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP1B1—prostate cancer	0.00035	0.000515	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PPP3CA—prostate cancer	0.000343	0.000504	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—THBS1—prostate cancer	0.000343	0.000504	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF10—prostate cancer	0.000341	0.000501	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GGT1—prostate cancer	0.000339	0.000498	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ANXA1—prostate cancer	0.000338	0.000496	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB2—prostate cancer	0.000337	0.000495	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NCOA1—prostate cancer	0.000334	0.000491	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—JAK2—prostate cancer	0.000333	0.000489	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCZ—prostate cancer	0.000332	0.000487	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—MAP2K1—prostate cancer	0.000332	0.000487	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP19A1—prostate cancer	0.000329	0.000484	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CD—prostate cancer	0.000329	0.000484	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VAV3—prostate cancer	0.000329	0.000483	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFBR2—prostate cancer	0.000324	0.000476	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CG—prostate cancer	0.000324	0.000476	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—EP300—prostate cancer	0.000324	0.000476	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGFR4—prostate cancer	0.00032	0.00047	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PARP1—prostate cancer	0.00032	0.00047	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ITPR1—prostate cancer	0.000319	0.000469	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—RXRA—prostate cancer	0.000318	0.000467	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CALCA—prostate cancer	0.000316	0.000465	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CB—prostate cancer	0.000316	0.000464	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SRC—prostate cancer	0.000315	0.000463	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL12—prostate cancer	0.000309	0.000454	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—prostate cancer	0.000307	0.000451	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—COMT—prostate cancer	0.000306	0.00045	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1R—prostate cancer	0.000305	0.000448	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTP1—prostate cancer	0.000305	0.000448	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCL8—prostate cancer	0.000304	0.000446	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—JAK2—prostate cancer	0.000302	0.000444	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ITPR1—prostate cancer	0.0003	0.00044	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CG—prostate cancer	0.000294	0.000432	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LPL—prostate cancer	0.000293	0.00043	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP9—prostate cancer	0.000291	0.000427	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—IL2—prostate cancer	0.00029	0.000426	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDGFRB—prostate cancer	0.00029	0.000426	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CB—prostate cancer	0.000287	0.000422	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CD—prostate cancer	0.000285	0.000419	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TYMS—prostate cancer	0.000283	0.000416	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ITGB3—prostate cancer	0.000283	0.000415	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCQ—prostate cancer	0.000282	0.000414	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NGFR—prostate cancer	0.000282	0.000414	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TGFB1—prostate cancer	0.000282	0.000414	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTM1—prostate cancer	0.00028	0.000411	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAP3K7—prostate cancer	0.000279	0.000409	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCL8—prostate cancer	0.000276	0.000405	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—LPL—prostate cancer	0.000275	0.000404	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ERBB3—prostate cancer	0.000274	0.000402	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGFR2—prostate cancer	0.000274	0.000402	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF10—prostate cancer	0.000268	0.000394	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP1A1—prostate cancer	0.000266	0.00039	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB2—prostate cancer	0.000265	0.000389	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL2—prostate cancer	0.000264	0.000387	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ERCC2—prostate cancer	0.000263	0.000387	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TERT—prostate cancer	0.000263	0.000386	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—JAK2—prostate cancer	0.000262	0.000384	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—KRAS—prostate cancer	0.000261	0.000383	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—MAP2K1—prostate cancer	0.000261	0.000383	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CD—prostate cancer	0.000259	0.00038	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VAV3—prostate cancer	0.000259	0.00038	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFBR2—prostate cancer	0.000255	0.000374	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HIF1A—prostate cancer	0.000251	0.000369	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ITPR1—prostate cancer	0.000251	0.000368	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CB—prostate cancer	0.000248	0.000365	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—MTHFR—prostate cancer	0.000248	0.000364	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—LEP—prostate cancer	0.000245	0.00036	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CAV1—prostate cancer	0.000243	0.000357	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PPARA—prostate cancer	0.000243	0.000357	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KDR—prostate cancer	0.00024	0.000353	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1R—prostate cancer	0.00024	0.000352	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PIK3CA—prostate cancer	0.00024	0.000352	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL8—prostate cancer	0.000239	0.000351	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—JAK2—prostate cancer	0.000238	0.000349	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ESR1—prostate cancer	0.000234	0.000344	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—TP53—prostate cancer	0.000232	0.00034	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LPL—prostate cancer	0.00023	0.000338	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—BAD—prostate cancer	0.000228	0.000336	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CAV1—prostate cancer	0.000228	0.000335	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IL2—prostate cancer	0.000228	0.000335	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDGFRB—prostate cancer	0.000228	0.000335	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CB—prostate cancer	0.000226	0.000331	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ITGB3—prostate cancer	0.000222	0.000326	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CG—prostate cancer	0.000221	0.000325	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APC—prostate cancer	0.000221	0.000325	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IRS1—prostate cancer	0.000219	0.000321	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGF—prostate cancer	0.000219	0.000321	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL8—prostate cancer	0.000217	0.000318	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ERBB3—prostate cancer	0.000215	0.000316	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGFR2—prostate cancer	0.000215	0.000316	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GSK3B—prostate cancer	0.000212	0.000312	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INS—prostate cancer	0.000209	0.000308	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CG—prostate cancer	0.000208	0.000305	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL2—prostate cancer	0.000207	0.000304	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TERT—prostate cancer	0.000206	0.000303	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CREBBP—prostate cancer	0.000205	0.000301	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1—prostate cancer	0.000203	0.000298	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EGFR—prostate cancer	0.000202	0.000296	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HIF1A—prostate cancer	0.000197	0.00029	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—INS—prostate cancer	0.000197	0.000289	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MAP2K1—prostate cancer	0.000196	0.000288	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—prostate cancer	0.000196	0.000287	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CD—prostate cancer	0.000195	0.000286	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CREBBP—prostate cancer	0.000193	0.000283	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—LEP—prostate cancer	0.000193	0.000283	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PIK3CA—prostate cancer	0.000193	0.000283	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SERPINE1—prostate cancer	0.000192	0.000283	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CAV1—prostate cancer	0.000191	0.00028	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—KRAS—prostate cancer	0.00019	0.00028	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KDR—prostate cancer	0.000189	0.000277	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF2—prostate cancer	0.000186	0.000274	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ESR1—prostate cancer	0.000184	0.00027	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOS3—prostate cancer	0.000184	0.00027	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CD—prostate cancer	0.000183	0.000269	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BAD—prostate cancer	0.00018	0.000264	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JAK2—prostate cancer	0.000179	0.000262	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	0.000175	0.000257	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MDM2—prostate cancer	0.000174	0.000256	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CG—prostate cancer	0.000174	0.000255	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APC—prostate cancer	0.000174	0.000255	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NOS3—prostate cancer	0.000173	0.000254	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IRS1—prostate cancer	0.000172	0.000252	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGF—prostate cancer	0.000172	0.000252	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ERBB2—prostate cancer	0.000172	0.000252	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	0.00017	0.000249	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GSK3B—prostate cancer	0.000167	0.000245	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INS—prostate cancer	0.000165	0.000242	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL8—prostate cancer	0.000163	0.000239	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CREBBP—prostate cancer	0.000161	0.000237	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CB—prostate cancer	0.000159	0.000234	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1—prostate cancer	0.000159	0.000234	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	0.000159	0.000234	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	0.000158	0.000233	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS2—prostate cancer	0.000158	0.000232	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	0.000157	0.000231	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—prostate cancer	0.000156	0.000229	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL2—prostate cancer	0.000156	0.000229	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—prostate cancer	0.000155	0.000228	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	0.000154	0.000226	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	0.000153	0.000225	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCND1—prostate cancer	0.000152	0.000223	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	0.000151	0.000222	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	0.000151	0.000222	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	0.00015	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	0.00015	0.00022	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP9—prostate cancer	0.000147	0.000216	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	0.000147	0.000216	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTEN—prostate cancer	0.000147	0.000215	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF2—prostate cancer	0.000146	0.000215	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOS3—prostate cancer	0.000144	0.000212	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—prostate cancer	0.000143	0.00021	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JAK2—prostate cancer	0.00014	0.000206	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EP300—prostate cancer	0.00014	0.000205	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTEN—prostate cancer	0.000138	0.000202	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	0.000138	0.000202	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MDM2—prostate cancer	0.000137	0.000201	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SRC—prostate cancer	0.000136	0.0002	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	0.000135	0.000198	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	0.000133	0.000196	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—prostate cancer	0.000132	0.000194	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—EP300—prostate cancer	0.000131	0.000193	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT3—prostate cancer	0.000131	0.000192	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	0.000128	0.000188	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	0.000125	0.000184	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	0.000124	0.000182	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—prostate cancer	0.000123	0.00018	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL2—prostate cancer	0.000122	0.00018	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—prostate cancer	0.000122	0.000179	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MYC—prostate cancer	0.000122	0.000179	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TGFB1—prostate cancer	0.000121	0.000178	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCND1—prostate cancer	0.000119	0.000175	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGFR—prostate cancer	0.000119	0.000175	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	0.000118	0.000174	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP9—prostate cancer	0.000116	0.00017	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	0.000115	0.000169	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTEN—prostate cancer	0.000115	0.000169	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KRAS—prostate cancer	0.000113	0.000165	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	0.000112	0.000165	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EP300—prostate cancer	0.00011	0.000161	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SRC—prostate cancer	0.000107	0.000157	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	0.000104	0.000153	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	0.000103	0.000152	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT3—prostate cancer	0.000103	0.000151	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TP53—prostate cancer	0.0001	0.000147	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PIK3CA—prostate cancer	9.72e-05	0.000143	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MYC—prostate cancer	9.57e-05	0.000141	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	9.55e-05	0.00014	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGFR—prostate cancer	9.36e-05	0.000137	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—prostate cancer	9.15e-05	0.000134	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KRAS—prostate cancer	8.84e-05	0.00013	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—prostate cancer	8.44e-05	0.000124	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	8.12e-05	0.000119	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—prostate cancer	7.94e-05	0.000117	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TP53—prostate cancer	7.86e-05	0.000115	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—prostate cancer	7.19e-05	0.000106	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—prostate cancer	6.64e-05	9.75e-05	CbGpPWpGaD
